Business UpdateMay 26, 2026, 04:07 PM
Seer to showcase AI-driven multi-cancer screening at ASMS 2026
AI Summary
Seer, Inc. announced its participation at the 2026 American Society for Mass Spectrometry (ASMS) Annual Conference, where it will showcase advancements in its Proteograph Product Suite. Key highlights include a preview of AI-driven proteomics for multi-cancer screening in collaboration with Korea University, analyzing over 20,000 clinical plasma samples. Seer will also introduce next-generation data processing tools, Radiant DIA and Fulcrum Pipeline, designed to significantly reduce runtime for large-scale proteomics studies. Additionally, numerous customer-led scientific presentations will demonstrate the growing adoption of Seer's technology across various research applications.
Key Highlights
- Seer to participate in the 2026 ASMS Annual Conference from May 31 to June 4.
- Featured breakfast symposium to preview AI-driven multi-cancer screening with Korea University.
- Collaboration with Korea University involves analyzing over 20,000 clinical plasma samples.
- Oral presentation to introduce Radiant DIA and Fulcrum Pipeline for scalable proteomics.
- Radiant DIA aims for an order-of-magnitude reduction in data processing runtime.
- Customer-led presentations will highlight diverse applications of Proteograph Product Suite.
- Presentations include HuBP database profiling over 10,000 proteins and Alzheimer's disease research.
Price Impact
More from SEER